Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-08
2011-03-08
Seaman, D. Margaret (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S310000, C514S312000, C514S313000, C346S150300, C346S150300, C346S150300, C346S141000, C346S141000, C346S106000
Reexamination Certificate
active
07902223
ABSTRACT:
Novel compounds of the formula (I), in which D, W, X, Y, T and R1are as defined in Patent Claim1, are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic diseases and for the treatment of tumors.
REFERENCES:
patent: 3279880 (1966-10-01), Straley et al.
patent: 28 15 820 (1978-10-01), None
patent: 00 71508 (2000-11-01), None
patent: 00 71510 (2000-11-01), None
patent: 00 71511 (2000-11-01), None
patent: 02 057236 (2002-07-01), None
Freshney, R. Ian, Culture of Animal Cells: A manuel of Basis Technique, New York, pp. 4-6, 2000.
Dermer, Gerald B., “Another Anniversary for the War on Cancer”, Bio/technology, vol. 12, p. 320, Mar. 1994.
L. Desaubry et al., “Synthesis of a Conformationally . . . Adenine Derivative”,Tetrahedron Letters, 36(24), pp. 4249-4252 (1995).
Barnes Christopher
Cezanne Bertram
Dorsch Dieter
Gleitz Johannes
Mederski Werner
Merck Patent GmbH
Millen White Zelano & Branigan P.C.
Seaman D. Margaret
LandOfFree
Phenyl derivatives as factor XA inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenyl derivatives as factor XA inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenyl derivatives as factor XA inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2720164